{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:29:46Z","timestamp":1769088586688,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670611"],"award-info":[{"award-number":["81670611"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12013-022-01094-0","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T13:02:44Z","timestamp":1664629364000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction of TSC2 knockout cell line using CRISPR\/Cas9 system and demonstration of its effects on NIH-3T3 cells"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-8163","authenticated-orcid":false,"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-2003","authenticated-orcid":false,"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2952-2692","authenticated-orcid":false,"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-1021","authenticated-orcid":false,"given":"Zhangcheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8058-9702","authenticated-orcid":false,"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske, E. P., J\u00f3\u017awiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016). Tuberous sclerosis complex. Nature Reviews. Disease Primers, 2, 16035 https:\/\/doi.org\/10.1038\/nrdp.2016.35.","journal-title":"Nature Reviews. Disease Primers"},{"key":"1094_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne, J. P., Fryer, A., & Webb, D. (1991). Epidemiology of tuberous sclerosis. Annals of the New York Academy of Sciences, 615, 125\u2013127. https:\/\/doi.org\/10.1111\/j.1749-6632.1991.tb37754.x.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"10","key":"1094_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.asjsur.2019.12.008","volume":"43","author":"T Hatano","year":"2020","unstructured":"Hatano, T., & Egawa, S. (2020). Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care. Asian Journal of Surgery, 43(10), 967\u2013972. https:\/\/doi.org\/10.1016\/j.asjsur.2019.12.008.","journal-title":"Asian Journal of Surgery"},{"issue":"3","key":"1094_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ajmg.c.31649","volume":"178","author":"Q-BD Nguyen","year":"2018","unstructured":"Nguyen, Q.-B. D., DarConte, M. D., & Hebert, A. A. (2018). The cutaneous manifestations of tuberous sclerosis complex. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 178(3), 321\u2013325. https:\/\/doi.org\/10.1002\/ajmg.c.31649.","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"key":"1094_CR5","doi-asserted-by":"publisher","first-page":"581102","DOI":"10.3389\/fneur.2021.581102","volume":"12","author":"K Bobeff","year":"2021","unstructured":"Bobeff, K., Krajewska, K., Baranska, D., Kotulska, K., Jozwiak, S., Mlynarski, W., & Trelinska, J. (2021). Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis - final results from the EMINENTS study. Frontiers in Neurology, 12, 581102 https:\/\/doi.org\/10.3389\/fneur.2021.581102.","journal-title":"Frontiers in Neurology"},{"issue":"5","key":"1094_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/ajmg.a.62120","volume":"185","author":"MP Silva-S\u00e1nchez","year":"2021","unstructured":"Silva-S\u00e1nchez, M. P., Alvarado-Socarras, J. L., Castro-Monsalve, J., Meneses, K. M., Santiago, J., & Prada, C. E. (2021). Everolimus for severe arrhythmias in tuberous sclerosis complex related cardiac rhabdomyomas. American Journal of Medical Genetics. Part A, 185(5), 1525\u20131531. https:\/\/doi.org\/10.1002\/ajmg.a.62120.","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"3","key":"1094_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ajmg.c.31638","volume":"178","author":"N Gupta","year":"2018","unstructured":"Gupta, N., & Henske, E. P. (2018). Pulmonary manifestations in tuberous sclerosis complex. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 178(3), 326\u2013337. https:\/\/doi.org\/10.1002\/ajmg.c.31638.","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"issue":"4","key":"1094_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00417-019-04476-y","volume":"258","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Xu, K., Long, Q., Yang, Z., Dai, R., Du, H., & Zhang, Z. (2020). Clinical features and optical coherence tomography findings of retinal astrocytic hamartomas in Chinese patients with tuberous sclerosis complex. Graefe\u2019s Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 258(4), 887\u2013892. https:\/\/doi.org\/10.1007\/s00417-019-04476-y.","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie"},{"issue":"9","key":"1094_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/iju.13390","volume":"24","author":"M Wataya-Kaneda","year":"2017","unstructured":"Wataya-Kaneda, M., Uemura, M., Fujita, K., Hirata, H., Osuga, K., & Kagitani-Shimono, K., Tuberous Sclerosis Complex Board of Osaka University Hospital. (2017). Tuberous sclerosis complex: Recent advances in manifestations and therapy. International Journal of Urology: Official Journal of the Japanese Urological Association, 24(9), 681\u2013691. https:\/\/doi.org\/10.1111\/iju.13390.","journal-title":"International Journal of Urology: Official Journal of the Japanese Urological Association"},{"issue":"3","key":"1094_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajmg.c.31654","volume":"178","author":"JJ Bissler","year":"2018","unstructured":"Bissler, J. J., & Christopher Kingswood, J. (2018). Renal manifestation of tuberous sclerosis complex. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 178(3), 338\u2013347. https:\/\/doi.org\/10.1002\/ajmg.c.31654.","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"issue":"11","key":"1094_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam, H. C., Siroky, B. J., & Henske, E. P. (2018). Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nature Reviews Nephrology, 14(11), 704\u2013716. https:\/\/doi.org\/10.1038\/s41581-018-0059-6.","journal-title":"Nature Reviews Nephrology"},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","volume":"46","author":"F Jiang","year":"2017","unstructured":"Jiang, F., & Doudna, J. A. (2017). CRISPR-Cas9 structures and mechanisms. Annual Review of Biophysics, 46, 505\u2013529. https:\/\/doi.org\/10.1146\/annurev-biophys-062215-010822.","journal-title":"Annual Review of Biophysics"},{"issue":"1","key":"1094_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/21655979.2018.1470720","volume":"9","author":"F Perez Rojo","year":"2018","unstructured":"Perez Rojo, F., Nyman, R. K. M., Johnson, A. A. T., Navarro, M. P., Ryan, M. H., Erskine, W., & Kaur, P. (2018). CRISPR-Cas systems: ushering in the new genome editing era. Bioengineered, 9(1), 214\u2013221. https:\/\/doi.org\/10.1080\/21655979.2018.1470720.","journal-title":"Bioengineered"},{"issue":"8","key":"1094_CR14","doi-asserted-by":"publisher","first-page":"12267","DOI":"10.1002\/jcp.27972","volume":"234","author":"A Karimian","year":"2019","unstructured":"Karimian, A., Azizian, K., Parsian, H., Rafieian, S., Shafiei-Irannejad, V., Kheyrollah, M., & Yousefi, B. (2019). CRISPR\/Cas9 technology as a potent molecular tool for gene therapy. Journal of Cellular Physiology, 234(8), 12267\u201312277. https:\/\/doi.org\/10.1002\/jcp.27972.","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"1094_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2009.12.033","volume":"37","author":"FV Karginov","year":"2010","unstructured":"Karginov, F. V., & Hannon, G. J. (2010). The CRISPR system: small RNA-guided defense in bacteria and archaea. Molecular Cell, 37(1), 7\u201319. https:\/\/doi.org\/10.1016\/j.molcel.2009.12.033.","journal-title":"Molecular Cell"},{"issue":"2","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","volume":"18","author":"KS Makarova","year":"2020","unstructured":"Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S. A., Alkhnbashi, O. S., Brouns, S. J. J., & Koonin, E. V. (2020). Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nature Reviews. Microbiology, 18(2), 67\u201383. https:\/\/doi.org\/10.1038\/s41579-019-0299-x.","journal-title":"Microbiology"},{"key":"1094_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen, M., Mao, A., Xu, M., Weng, Q., Mao, J., & Ji, J. (2019). CRISPR-Cas9 for cancer therapy: Opportunities and challenges. Cancer Letters, 447, 48\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.017.","journal-title":"Cancer Letters"},{"issue":"1","key":"1094_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04252-2","volume":"9","author":"M Adli","year":"2018","unstructured":"Adli, M. (2018). The CRISPR tool kit for genome editing and beyond. Nature Communications, 9(1), 1911 https:\/\/doi.org\/10.1038\/s41467-018-04252-2.","journal-title":"Nature Communications"},{"issue":"4","key":"1094_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/jcp.30064","volume":"236","author":"B Zhang","year":"2021","unstructured":"Zhang, B. (2021). CRISPR\/Cas gene therapy. Journal of Cellular Physiology, 236(4), 2459\u20132481. https:\/\/doi.org\/10.1002\/jcp.30064.","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"1094_CR20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/nprot.2018.042","volume":"13","author":"B Koch","year":"2018","unstructured":"Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018). Generation and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing. Nature Protocols, 13(6), 1465\u20131487. https:\/\/doi.org\/10.1038\/nprot.2018.042.","journal-title":"Nature Protocols"},{"issue":"1","key":"1094_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/21623945.2020.1834230","volume":"9","author":"M Mandl","year":"2020","unstructured":"Mandl, M., Ritthammer, H., Ejaz, A., Wagner, S. A., Hatzmann, F. M., Baumgarten, S., & Zwerschke, W. (2020). CRISPR\/Cas9-mediated gene knockout in human adipose stem\/progenitor cells. Adipocyte, 9(1), 626\u2013635. https:\/\/doi.org\/10.1080\/21623945.2020.1834230.","journal-title":"Adipocyte"},{"issue":"22","key":"1094_CR22","doi-asserted-by":"publisher","first-page":"E5706","DOI":"10.3390\/ijms20225706","volume":"20","author":"E Lentsch","year":"2019","unstructured":"Lentsch, E., Li, L., Pfeffer, S., Ekici, A. B., Taher, L., Pilarsky, C., & Gr\u00fctzmann, R. (2019). CRISPR\/Cas9-mediated knock-out of KrasG12D mutated pancreatic cancer cell lines. International Journal of Molecular Sciences, 20(22), E5706 https:\/\/doi.org\/10.3390\/ijms20225706.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"1094_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","volume":"93","author":"LKL Portocarrero","year":"2018","unstructured":"Portocarrero, L. K. L., Quental, K. N., Samorano, L. P., de Oliveira, Z. N. P., & da M. Rivitti-Machado, M. C. (2018). Tuberous sclerosis complex: review based on new diagnostic criteria. Anais Brasileiros De Dermatologia, 93(3), 323\u2013331. https:\/\/doi.org\/10.1590\/abd1806-4841.20186972.","journal-title":"Anais Brasileiros De Dermatologia"},{"issue":"1","key":"1094_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., & Kwiatkowski, D. J. (2001). Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. The American Journal of Human Genetics, 68(1), 64\u201380. https:\/\/doi.org\/10.1086\/316951.","journal-title":"The American Journal of Human Genetics"},{"key":"1094_CR25","doi-asserted-by":"publisher","first-page":"170.e1","DOI":"10.1016\/j.urology.2016.10.056","volume":"101","author":"Y Cai","year":"2017","unstructured":"Cai, Y., Li, H., & Zhang, Y. (2017). Assessment of tuberous sclerosis complex associated with renal lesions by targeted next-generation sequencing in mainland China. Urology, 101, 170.e1\u2013170.e7. https:\/\/doi.org\/10.1016\/j.urology.2016.10.056.","journal-title":"Urology"},{"issue":"7810","key":"1094_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-020-2227-7","volume":"582","author":"DE Muench","year":"2020","unstructured":"Muench, D. E., Olsson, A., Ferchen, K., Pham, G., Serafin, R. A., Chutipongtanate, S., & Grimes, H. L. (2020). Mouse models of neutropenia reveal progenitor-stage-specific defects. Nature, 582(7810), 109\u2013114. https:\/\/doi.org\/10.1038\/s41586-020-2227-7.","journal-title":"Nature"},{"key":"1094_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","volume":"46","author":"P Dwivedi","year":"2017","unstructured":"Dwivedi, P., & Greis, K. D. (2017). Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies. Experimental Hematology, 46, 9\u201320. https:\/\/doi.org\/10.1016\/j.exphem.2016.10.008.","journal-title":"Experimental Hematology"},{"issue":"1","key":"1094_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41375-018-0188-8","volume":"33","author":"P Dwivedi","year":"2019","unstructured":"Dwivedi, P., Muench, D. E., Wagner, M., Azam, M., Grimes, H. L., & Greis, K. D. (2019). Time resolved quantitative phospho-tyrosine analysis reveals Bruton\u2019s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors. Leukemia, 33(1), 75\u201387. https:\/\/doi.org\/10.1038\/s41375-018-0188-8.","journal-title":"Leukemia"},{"issue":"1","key":"1094_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-020-0320-2","volume":"11","author":"W Afshar Saber","year":"2020","unstructured":"Afshar Saber, W., & Sahin, M. (2020). Recent advances in human stem cell-based modeling of Tuberous Sclerosis Complex. Molecular Autism, 11(1), 16 https:\/\/doi.org\/10.1186\/s13229-020-0320-2.","journal-title":"Molecular Autism"},{"issue":"6","key":"1094_CR30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A., & Sabatini, D. M. (2017). mTOR signaling in growth, metabolism, and disease. Cell, 168(6), 960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004.","journal-title":"Cell"},{"issue":"5","key":"1094_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M., & Blenis, J. (2009). Molecular mechanisms of mTOR-mediated translational control. Nature Reviews. Molecular Cell Biology, 10(5), 307\u2013318. https:\/\/doi.org\/10.1038\/nrm2672.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"7448","key":"1094_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"H Yang","year":"2013","unstructured":"Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., & Pavletich, N. P. (2013). mTOR kinase structure, mechanism and regulation. Nature, 497(7448), 217\u2013223. https:\/\/doi.org\/10.1038\/nature12122.","journal-title":"Nature"},{"issue":"8","key":"1094_CR33","doi-asserted-by":"publisher","first-page":"L703","DOI":"10.1152\/ajplung.00414.2011","volume":"303","author":"LM Moir","year":"2012","unstructured":"Moir, L. M., Black, J. L., & Krymskaya, V. P. (2012). TSC2 modulates cell adhesion and migration via integrin-\u03b11\u03b21. American Journal of Physiology. Lung Cellular and Molecular Physiology, 303(8), L703\u2013710. https:\/\/doi.org\/10.1152\/ajplung.00414.2011.","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"9869","key":"1094_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler, J. J., Kingswood, J. C., Radzikowska, E., Zonnenberg, B. A., Frost, M., Belousova, E., & Budde, K. (2013). Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (London, England), 381(9869), 817\u2013824. https:\/\/doi.org\/10.1016\/S0140-6736(12)61767-X.","journal-title":"Lancet (London, England)"},{"issue":"9861","key":"1094_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz, D. N., Belousova, E., Sparagana, S., Bebin, E. M., Frost, M., Kuperman, R., & Jozwiak, S. (2013). Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet (London, England), 381(9861), 125\u2013132. https:\/\/doi.org\/10.1016\/S0140-6736(12)61134-9.","journal-title":"Lancet (London, England)"},{"issue":"17","key":"1094_CR36","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., & Nakata, K., MILES Trial Group. (2011). Efficacy and safety of sirolimus in lymphangioleiomyomatosis. The New England Journal of Medicine, 364(17), 1595\u20131606. https:\/\/doi.org\/10.1056\/NEJMoa1100391.","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"1094_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger, D. A., & Northrup, H. (2013). Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatric Neurology, 49(4), 255\u2013265. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.002.","journal-title":"Pediatric Neurology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-022-01094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-022-01094-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-022-01094-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T07:52:15Z","timestamp":1665733935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-022-01094-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s12013-022-01094-0","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}